Journal profile · MEDICINE, RESEARCH & EXPERIMENTAL
Indonesian Biomedical Journal
ISSN 2355-9179 · Secretariat of The Indonesian Biomedical Journal · Indonesia
Indonesian Biomedical Journal: CAS Zone 4 · Medicine (2025 upgraded edition); fully open access; APC about USD 200; review about 16 weeks (community reports); 60 articles in 2025; indexed in ESCI and Scopus.
Scope
Aims, scope and focus
Indonesian Biomedical Journal is published by Secretariat of The Indonesian Biomedical Journal and is in Zone 4 of Medicine in the CAS Journal Ranking (2025 upgraded edition). By OpenAlex counts of its recent articles, its largest topics are Adipokines, Inflammation, and Metabolic Diseases, Adipose Tissue and Metabolism and MicroRNA in disease regulation, together about 29% of its articles. (generated from OpenAlex topic counts and CAS ranking data)
The Indonesian Biomedical Journal (InaBJ) is an open access, peer-reviewed journal that encompasses all fundamental and molecular aspects of basic medical sciences, emphasizing on providing the molecular studies of biomedical problems and molecular mechanisms. InaBJ is dedicated to publish original research and review articles covering all aspects in biomedical sciences. The editors will carefully select manuscript to present only the most recent findings in basic and clinical sciences. All professionals concerned with biomedical issues will find this journal a most valuable update to keep them abreast of the latest scientific development.
From the journal's Aims & Scope
Research area (LetPub): MEDICINE, RESEARCH & EXPERIMENTAL
Editor-in-chief Dewi MuliatyPublisher website
Editorial board by country: none in mainland China; most named Indonesia 6, United States 1, Japan 1, Italy 1, Philippines 1 (10 members with a country) Editorial board ↗Publisher website ·
Main research topics OpenAlex counts of recent articles; shares are approximate
- Adipokines, Inflammation, and Metabolic DiseasesMedicine13.6%
- Adipose Tissue and MetabolismMedicine9.9%
- MicroRNA in disease regulationBiochemistry, Genetics and Molecular Biology5.5%
- Cardiovascular Disease and AdiposityMedicine4.8%
- Diet and metabolism studiesMedicine4.6%
- Mesenchymal stem cell researchMedicine4.4%
- Pregnancy and preeclampsia studiesMedicine4.2%
- Diabetes, Cardiovascular Risks, and LipoproteinsMedicine3.9%
Rankings & indexing
CAS ranking and database indexing
CAS Journal Ranking
CAS Journal Ranking, upgraded edition (March 2025)Medicine Zone 4
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 4 |
| Minor | Medicine, Research & Experimental | Zone 4 |
Top journal: noReview journal: no
CAS Xinrui Journal Ranking (March 2026)Medicine Zone 4
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 4 |
| Minor | Medicine, Research & Experimental | Zone 4 |
Top journal: noReview journal: not marked
CAS Journal Ranking, previous upgraded edition (December 2023)Not covered
Not covered by this edition.
Database indexing
ESCIScopusDOAJLetPub
International journal early-warning lists: not listed in any editionLetPub
Indexing the journal's website claims
ClarivatePublisher website
As the journal's website lists them, not checked against each database; for Web of Science editions the records above apply.
Editions, and major and minor categories, are shown separately and never merged into one zone; check which edition your institution uses before you submit or report.
Metrics
Impact metrics and publication volume
Impact
- CiteScore 2026-06
- 1.6LetPub ·
- SJR 2026-06
- 0.24LetPub ·
- SNIP 2026-06
- 0.38LetPub ·
- h-index
- 17OpenAlex ·
- i10-index
- 49OpenAlex ·
- 2-year mean citedness
- 0.76OpenAlex ·
- Self-citation rate
- 55.6%LetPub ·
- Share of gold OA articles
- 97.75%LetPub ·
Volume
- Articles per year
- 60LetPub ·
Articles by year OpenAlex count · 651 in total · the current year is incomplete
| Year | Articles | Open access | Citations |
|---|---|---|---|
| 2026 | 40 | 40 | 1 |
| 2025 | 60 | 60 | 21 |
| 2024 | 60 | 60 | 99 |
| 2023 | 60 | 60 | 123 |
| 2022 | 52 | 52 | 167 |
| 2021 | 52 | 52 | 208 |
Sources count differently and were observed at different times, so each source's own value is kept; "publisher" marks figures from the journal's website.
Review & acceptance
Review time and acceptance
- Average review time (community reports)
- about 16 weeksLetPub ·
- Submission to publication (journal-reported)
- about 16 weeksDOAJ ·
- Peer review
- Single anonymous peer reviewDOAJ
Community reports come from authors' own submissions (confidence 0.5) and are not a promise from the journal; for publisher figures, the journal's own definitions apply.
Fees & open access
APC and open-access policy
Fully open accessDOAJ
Every article is open access; authors usually pay an article processing charge (APC).
| Source | APC | Fee waiver | License | Observed |
|---|---|---|---|---|
| DOAJ | USD 200 / IDR 2,000,000 | No | CC BY-NC | |
| OpenAlex | USD 200 / IDR 2,000,000 | — | — | |
| LetPub | USD 200 / IDR 2,000,000 | No | — | |
| Publisher website | USD 500 | — | — |
The journal's website is authoritative for fees; sources were observed at different times and each keeps its own value, without averaging.
Submission
Article types and submission policies (journal website)
What to prepare4 items from the author guidelines
- Abstract
- ≤ 300 words
- Manuscript length
- ≤ 10,000 words
- Reference style
- Vancouver
- First submission
- Free format: the journal's layout is not required
Article types accepted4, with length limits
- original researchlnaBJ is dedicated to publishing original research and review articles covering all aspects of biomedical sciences.Length not stated
- research articleReview Article: Review Article should consist of no more than 10,000 words, not including the words in abstract, references, table, figure, and figure legend. T…main text ≤ 3,500 words
- reviewlnaBJ is dedicated to publishing original research and review articles covering all aspects of biomedical sciences.Length not stated
- review articleReview Article: Review Article should consist of no more than 10,000 words, not including the words in abstract, references, table, figure, and figure legend. T…main text ≤ 10,000 words
Policy excerpts from the journal's websiteAuthorship, Conflicts of interest, Data availability, Publication ethics, License & copyright, Open access, Peer review, Plagiarism
- Authorship Authorship Criteria
Authorship provides credit for an author's contributions to a study and carries accountability. Authorship should be limited to those who have made a significant contribution to the conception, design, execution, analysis and interpretation, as well as manuscript preparation and revision. Transparency about the contributions of authors is encouraged. In order to qualify for authorship of the submi…
Source ↗Publisher website ·- Conflicts of interest Conflict of Interest Policy
A conflict of interest exists when professional judgment concerning a primary interest may be influenced by a secondary interest. These instructions are based on ICJME recommendation for scholarly work in medical journal: Author’s Conflict of Interest At the point of submission, InaBJ requires that each author reveal any personal and/or financial interests or connections, direct or indirect, or ot…
Source ↗Publisher website ·- Data availability Data Sharing and Reproducibility
To enable the openness, transparency, reproducibility and verification of data, InaBJ encourages authors to share information related with their research data including, but not limited to: raw data, processed data, software, algorithms, protocols, methods and materials. InaBJ also requires data sharing plans for registered clinical trials. Any clinical trial study that enrolling participants must…
Source ↗Publisher website ·- Publication ethics Allegations of Misconduct
Scientific misconduct is a wilful violation of standard codes of scholarly conduct and ethical behaviour in the publication of professional scientific research, which includes fabrication, falsification, or plagiarism in proposing, performing, reviewing research, or in reporting research results. Misconduct represents a tremendous attack on the values upon which science is based, and will be taken…
Source ↗Publisher website ·- License & copyright Copyright Notice
Author/s who publish in InaBJ will transfer the copyright of their work to PERI. By submitting a manuscript, the author/s agree that the copyright of their manuscript is transferred to PERI, if and when the manuscript is accepted for publication. Once submitted to the journal, the author/s will not withdraw their manuscript at any stage prior to publication. However, the copyright will be released…
Source ↗Publisher website ·- Open access Open Access Policy
Open access under CC-BY-NC license; no commercial use. Model summary
InaBJ provides immediate open access to its content on the principle that making research freely available to the public supports a greater global exchange of knowledge.
Source ↗Publisher website ·- Peer review Peer Review Process
Review articles are by invitation only. Model summary
All manuscripts submitted to InaBJ will be selected and double-blind peer-reviewed by two or more reviewers to present valuable and authentic findings in biomedical sciences. At least, an external reviewer will be included as the reviewer in each manuscript reviewing process. Author can suggest reviewer/s that not having publication together within five years and should not be member/s of the same…
Source ↗Publisher website ·- Plagiarism Plagiarism Screening Policy
Plagiarism is strictly forbidden, and by submitting the manuscript for publication the author/s agree that the publishers have the legal right to take appropriate action against the author/s if plagiarism or fabricated information is discovered. All manuscripts submitted to InaBJ will be screened for plagiarism by using Turnitin and/or Crossref Similarity Check.
Source ↗Publisher website ·
Excerpts are quoted from the journal's website; "model summary" lines are written by Workers AI and checked against the text. The journal's website is authoritative.
Profile
Publication details and official links
- Publisher
- Secretariat of The Indonesian Biomedical Journal
- Country or region
- Indonesia
- Language
- English
- ISSN
- 2355-9179
- Print ISSN
- 2085-3297
- Official links
- Journal homepage ↗LetPub
- Author guidelines ↗LetPub
- Aims & Scope ↗LetPub
- APC information ↗DOAJ
- Open access statement ↗DOAJ
- License & copyright ↗DOAJ
- Peer review process ↗LetPub
- Editorial board ↗LetPub
- Plagiarism policy ↗DOAJ
FAQ
Frequently asked questions about Indonesian Biomedical Journal
What CAS zone is Indonesian Biomedical Journal in?
In the 2025 upgraded edition of the CAS Journal Ranking, Indonesian Biomedical Journal is in Zone 4 of Medicine, and in Zone 4 of the minor category Medicine, Research & Experimental. In the 2026 Xinrui edition it is in Zone 4 of Medicine. Zones from different editions, and from major and minor categories, are not interchangeable.
How long does peer review take at Indonesian Biomedical Journal?
Authors report an average review time of about 16 weeks. Article statistics cover accepted papers only, publisher figures follow the journal's own definitions, and community reports come from authors' own submissions; none is a promise from the journal.
What are the manuscript requirements of Indonesian Biomedical Journal?
According to the journal's author guidelines: Abstract: ≤ 300 words; Manuscript length: ≤ 10,000 words; Reference style: Vancouver; First submission: Free format: the journal's layout is not required. A model extracted these from the author guidelines and each was checked against the text; check the latest version on the journal's website before submitting.
Where are the editorial board members of Indonesian Biomedical Journal based?
Of the 10 board members whose country the journal's board page names, none are in mainland China; the countries named most often are Indonesia (6), United States (1) and Japan (1). Counted from the institutions listed on the board page; for reference only.
Which databases index Indonesian Biomedical Journal?
According to LetPub and DOAJ records, Indonesian Biomedical Journal is indexed in ESCI, Scopus and DOAJ.
Is Indonesian Biomedical Journal open access, and what is the APC?
Indonesian Biomedical Journal is a fully open-access journal. APC about USD 200.
Sources and updates
The facts on this page come from LetPub, OpenAlex, DOAJ, Publisher website; every figure is tagged with its source and the date it was observed, and conflicting values are kept per source. LetPub source page: view ↗ (archived 2026-08-25). Last updated: .